Physician
Medical Practices of Antietam, LLC
Medical Practices of Antietam, LLC was paid $20.56M by Medicaid between Jan 2018 and Dec 2024, across 159 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 42% of everything it billed.
33Billing provider infoMEDICAL PRACTICES OF ANTIETAM, LLC
HAGERSTOWN, MD 21742
HAGERSTOWN, MD 21742
33aNPI1558430843assigned 11/08/2006
33bProvider typeGeneral Practice Physician
28Total paid$20.56M
24GClaims447,864
24DCodes billed159
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Practice Physician providers in Maryland
Rank by total paid#3 of 40
Median peer was paid$190K
This provider vs. median108×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official REPAC, JOSHUA controls 17+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 10,516 | $819K | |
| 2019 | 10,481 | $582K | |
| 2020 | 34,646 | $1.71M | |
| 2021 | 55,539 | $2.47M | |
| 2022 | 94,923 | $4.71M | |
| 2023 | 112,799 | $5.69M | |
| 2024incomplete | 128,960 | $4.58M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 42% | 105,839 | 86,074 | $8.56M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 33% | 104,313 | 84,497 | $6.83M |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 4.7% | 9,505 | 8,092 | $976K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 2.1% | 5,708 | 4,990 | $436K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 2.0% | 10,415 | 8,383 | $420K |
| 99254 | 1.1% | 1,482 | 1,344 | $234K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 4,127 | 3,386 | $204K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 2,495 | 2,150 | $204K |
| 99232 | Hospital visit by a doctor, follow-up daySubsequent hospital care, per day, moderate complexity | <1% | 8,384 | 2,473 | $191K |
| 93000 | <1% | 7,145 | 6,156 | $135K | |
| 99051 | <1% | 10,278 | 8,098 | $123K | |
| 99222 | Initial hospital care, per day, moderate complexity | <1% | 3,532 | 2,627 | $122K |
147 more codes
| 95165 | Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials | <1% | 502 | $120K |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 3,864 | $112K |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 18,070 | $102K |
| L4361 | Walking boot, pneumatic and/or vacuum, with or without joints, with or without interface material, prefabricated, off-the-shelf | <1% | 461 | $94K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 2,142 | $84K |
| 73630 | <1% | 2,550 | $58K | |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 726 | $57K |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 1,821 | $56K |
| 3044F | <1% | 3,965 | $56K | |
| 95117 | <1% | 5,306 | $55K | |
| L3000 | Foot, insert, removable, molded to patient model, 'ucb' type, berkeley shell, each | <1% | 166 | $54K |
| 0002A | <1% | 2,786 | $52K | |
| 0001A | <1% | 3,033 | $50K | |
| 99244 | Office or other outpatient consultation, moderate to high complexity | <1% | 292 | $49K |
| 20611 | <1% | 1,357 | $46K | |
| 87428 | <1% | 1,711 | $45K | |
| 95004 | Percutaneous tests with allergenic extracts, immediate type reaction | <1% | 417 | $44K |
| 99308 | Subsequent nursing facility care, per day, straightforward | <1% | 1,763 | $42K |
| 76819 | Fetal biophysical profile; without non-stress testing | <1% | 616 | $41K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 377 | $41K |
| 90686 | <1% | 2,390 | $38K | |
| 88342 | <1% | 1,095 | $35K | |
| 88307 | <1% | 518 | $34K | |
| 93015 | <1% | 426 | $33K | |
| 99221 | <1% | 449 | $32K | |
| 94727 | <1% | 1,459 | $30K | |
| 99223 | Prolong inpt eval add15 m | <1% | 661 | $29K |
| 94729 | <1% | 1,566 | $29K | |
| 80305 | <1% | 1,628 | $29K | |
| 94060 | <1% | 1,567 | $27K | |
| 76820 | <1% | 629 | $26K | |
| 99231 | Subsequent hospital care, per day, straightforward or low complexity | <1% | 1,209 | $23K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 2,258 | $22K |
| 99309 | Subsequent nursing facility care, per day, low to moderate complexity | <1% | 705 | $22K |
| 99205 | Prolong outpt/office vis | <1% | 311 | $21K |
| 0003A | <1% | 1,193 | $20K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 1,633 | $20K |
| 95251 | <1% | 713 | $20K | |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 175 | $17K |
| G0008 | Administration of influenza virus vaccine | <1% | 1,571 | $16K |
| 90682 | <1% | 704 | $16K | |
| 0012A | <1% | 910 | $15K | |
| 0064A | <1% | 829 | $15K | |
| 73564 | <1% | 678 | $15K | |
| 99442 | <1% | 608 | $14K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 147 | $14K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 151 | $14K |
| 0011A | <1% | 1,033 | $14K | |
| H1003 | Prenatal care, at-risk enhanced service; education | <1% | 1,208 | $12K |
| 1125F | <1% | 730 | $11K | |
| 99406 | <1% | 1,327 | $11K | |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 73 | $11K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 1,274 | $10K |
| 0072A | <1% | 540 | $10K | |
| 3051F | <1% | 352 | $10K | |
| 99443 | <1% | 293 | $9K | |
| 99233 | Hospital visit by a doctor, follow-up day (complex) | <1% | 526 | $9K |
| 0071A | <1% | 541 | $9K | |
| 73130 | <1% | 295 | $7K | |
| 81003 | <1% | 530 | $7K | |
| 1126F | <1% | 442 | $6K | |
| 0031A | <1% | 316 | $6K | |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 81 | $5K |
| 99239 | Hospital discharge day management, more than 30 minutes | <1% | 263 | $5K |
| 73610 | <1% | 173 | $4K | |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 53 | $4K |
| 91320 | <1% | 83 | $4K | |
| 90656 | <1% | 233 | $4K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 179 | $4K |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 30 | $4K |
| 3052F | <1% | 130 | $3K | |
| 99441 | <1% | 224 | $3K | |
| 11721 | <1% | 86 | $3K | |
| 73030 | <1% | 77 | $3K | |
| 76801 | <1% | 26 | $3K | |
| 0004A | <1% | 145 | $3K | |
| 81025 | <1% | 433 | $3K | |
| 95024 | <1% | 16 | $2K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 67 | $2K |
| 0124A | <1% | 115 | $2K | |
| 0054A | <1% | 103 | $2K | |
| 94010 | <1% | 74 | $2K | |
| 90662 | <1% | 342 | $2K | |
| 93356 | <1% | 67 | $2K | |
| 88304 | <1% | 165 | $2K | |
| 3046F | <1% | 73 | $2K | |
| 94618 | <1% | 65 | $2K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 13 | $2K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 46 | $2K |
| 99385 | <1% | 12 | $2K | |
| 0134A | <1% | 64 | $2K | |
| 90480 | <1% | 83 | $1K | |
| 72100 | <1% | 56 | $1K | |
| 0052A | <1% | 74 | $1K | |
| 20610 | <1% | 103 | $1K | |
| 99417 | Prolong home eval add 15m | <1% | 60 | $1K |
| 99459 | <1% | 58 | $1K | |
| J2785 | Injection, regadenoson, 0.1 mg | <1% | 255 | $1K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 12 | $1K |
| 96160 | <1% | 461 | $1K | |
| 88141 | <1% | 47 | $988.86 | |
| 0051A | <1% | 57 | $974.00 | |
| 82803 | <1% | 26 | $969.15 | |
| 90648 | <1% | 87 | $884.64 | |
| G0009 | Administration of pneumococcal vaccine | <1% | 85 | $881.85 |
| 99495 | <1% | 27 | $877.44 | |
| 90715 | <1% | 26 | $862.02 | |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 43 | $819.80 |
| 87807 | <1% | 76 | $785.20 | |
| 73502 | <1% | 31 | $764.92 | |
| 93793 | <1% | 660 | $618.35 | |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 293 | $562.69 |
| 88112 | <1% | 16 | $556.78 | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 27 | $554.88 |
| 99496 | <1% | 14 | $497.63 | |
| H1000 | Prenatal care, at-risk assessment | <1% | 12 | $480.00 |
| 0013A | <1% | 25 | $480.00 | |
| 94664 | <1% | 33 | $460.60 | |
| 82962 | <1% | 143 | $370.62 | |
| 81000 | <1% | 114 | $365.76 | |
| 99307 | <1% | 36 | $292.41 | |
| 90670 | <1% | 43 | $232.80 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 17 | $191.38 |
| 3008F | <1% | 23,505 | $120.00 | |
| 3074F | <1% | 13,102 | $75.00 | |
| 87081 | <1% | 13 | $65.33 | |
| 85610 | <1% | 23 | $46.36 | |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | <1% | 49 | $30.00 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 22 | $11.25 |
| 3075F | <1% | 676 | $8.79 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 17 | $2.04 |
| 91300 | <1% | 53 | $0.04 | |
| 0502F | 0% | 14,768 | $0.00 | |
| 1159F | 0% | 10,177 | $0.00 | |
| 3078F | 0% | 11,076 | $0.00 | |
| 1160F | 0% | 3,222 | $0.00 | |
| 3077F | 0% | 181 | $0.00 | |
| 3079F | 0% | 2,626 | $0.00 | |
| 3048F | 0% | 267 | $0.00 | |
| 4010F | 0% | 502 | $0.00 | |
| 3049F | 0% | 73 | $0.00 | |
| 90677 | 0% | 30 | $0.00 | |
| 3080F | 0% | 26 | $0.00 | |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | 0% | 50 | $0.00 |
| 91301 | 0% | 15 | $0.00 | |
| 90732 | 0% | 15 | $0.00 | |
| 36600 | 0% | 27 | $-5.32 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialREPAC, JOSHUA (CFO)
| Provider | Location | Paid |
|---|---|---|
| Meritus Medical Laboratory LLC | Hagerstown, MD | $12.14M |
| Brook Lane Behavioral Services, INC. | Frederick, MD | $5.59M |
| Meritus Urgent Care, LLC | Hagerstown, MD | $4.93M |
| Meritus Medical Center INC | Hagerstown, MD | $3.41M |
| Brook Lane Behavioral Services, INC. | Hagerstown, MD | $3.12M |
| Meritus Medical Center INC | Hagerstown, MD | $1.47M |
| Meritus Enterprises,inc. | Hagerstown, MD | $1.28M |
| Meritus Medical Center INC | Hagerstown, MD | $1.18M |
| Meritus Medical Center INC | Hagerstown, MD | $968K |
| Meritus Medical Center INC | Hagerstown, MD | $828K |
| Meritus Medical Center INC | Hagerstown, MD | $517K |
| Meritus Medical Center INC | Hagerstown, MD | $60K |
| Meritus Medical Center INC | Hagerstown, MD | $49K |
| Meritus Medical Center INC | Hagerstown, MD | $17K |
| Meritus Medical Center INC | Hagerstown, MD | $2K |
| Meritus Medical Center, INC. | Hagerstown, MD | $796.87 |
| Meritus Urgent Care LLC | Hagerstown, MD | $92.10 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.